Appointment booking for Dr. Julia Zefirova, MD is currently not available.Dr. Julia Zefirova, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Julia Zefirova, MD (she/her) is a Internist in Pittsburgh, PA with over 15 years of experience. What is your opinion of Dr. Julia Zefirova, MD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 15 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Julia Zefirova, MD has received over $4,896 which includes payments from the following companies:
$779.86 from GlaxoSmithKline, LLC.
$486.08 from Pfizer Inc.
$468.16 from LILLY USA, LLC
$407.55 from Takeda Pharmaceuticals America, Inc.
$309.89 from sanofi-aventis U.S. LLC
$268.23 from Allergan Inc.
$261.01 from Novo Nordisk Inc
$244.70 from Janssen Pharmaceuticals, Inc
$233.82 from Amgen Inc.
$233.52 from Boehringer Ingelheim Pharmaceuticals, Inc.
$177.23 from AstraZeneca Pharmaceuticals LP
$164.13 from AbbVie, Inc.
$130.90 from Astellas Pharma US Inc
$81.51 from Actavis Pharma Inc
$67.67 from Sanofi Pasteur Inc.
$66.46 from Merck Sharp & Dohme Corporation
$63.64 from Valeritas, Inc.
$36.33 from Daiichi Sankyo Inc.
$34.98 from Purdue Pharma L.P.
$34.51 from Kowa Pharmaceuticals America, Inc.
Payments received by Dr. Julia Zefirova, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!